Legal Representation
Attorney
Janina Gorbach
USPTO Deadlines
Next Deadline
245 days remaining
NOA E-Mailed - SOU Required
Due Date
August 18, 2026
Extension Available
Until February 18, 2027
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 6, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 5, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Dec 5, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Dec 5, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 4, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Dec 4, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Dec 4, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Dec 4, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jul 23, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 22, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 22, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 22, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 18, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 24, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 24, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 18, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 30, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 25, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 17, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 17, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
Classification
International Classes
005